SLC2A9 and Parkinson disease: To the best of our knowledge, this is the first study to follow up recent GWAS finding on SLC2A9 and plasma urate for PD research, and some of these SNPs were included in the above-mentioned studies on gout and cardiovascular diseases [8,9].